Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Historical Holders from Q2 2016 to Q2 2023

Symbol
SYRS on Nasdaq
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
28M
All holders as of 30 Jun 2023
Q2 2023
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Invus Global Management, LLC 3.8% $777K 1.06M Invus Public Equities, L.P. 31 Dec 2024

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2023 Q2 0 $0 -$585 0
2023 Q1 219 $585 $2.67 1
2022 Q4 219 $786 -$5.68M $3.59 1
2022 Q3 882K $5.68M -$38.9M $6.44 3
2022 Q2 35.6M $34.2M -$9.55M $0.96 58
2022 Q1 44.6M $53.1M -$16.2M $1.19 86
2021 Q4 51.2M $166M +$2.42M $3.26 84
2021 Q3 47.2M $210M -$4.8M $4.47 92
2021 Q2 47.9M $260M -$108M $5.45 95
2021 Q1 60.9M $454M +$51.3M $7.48 99
2020 Q4 53.6M $580M +$89.5M $10.85 99
2020 Q3 46M $406M +$16.2M $8.84 91
2020 Q2 40M $425M +$6.98M $10.66 77
2020 Q1 44.9M $265M +$15.2M $5.93 63
2019 Q4 42.2M $291M -$8.98M $6.91 70
2019 Q3 43.1M $446M +$89M $10.38 61
2019 Q2 31.6M $292M +$103M $9.26 66
2019 Q1 20.6M $188M +$16.1M $9.14 63
2018 Q4 22.2M $124M +$995K $5.57 67
2018 Q3 17.4M $207M +$2.48M $11.91 73
2018 Q2 17.2M $176M +$16.5M $10.21 73
2018 Q1 18.5M $240M +$38.7M $12.98 54
2017 Q4 15.9M $154M +$4.67M $9.73 68
2017 Q3 12M $177M +$16.4M $14.72 66
2017 Q2 10.8M $174M +$43.6M $16.09 45
2017 Q1 12.9M $205M +$2.13M $15.93 42
2016 Q4 12.9M $157M +$1.76M $12.16 40
2016 Q3 12.8M $176M +$3.96M $13.87 34
2016 Q2 7.67M $120M +$120M $18.15 11